Skip to main content

Role of Pancreatic Stone Protein as an Early Biomarker for Risk Stratification of Acute Pancreatitis

Digestive Diseases and Sciences volume 67, pages 3275–3283 (2022)Cite this article

Abstract

Background

Early risk stratification of acute pancreatitis is crucial to improve clinical outcomes. The objective of this study was to evaluate the ability of pancreatic stone protein (PSP) to predict acute pancreatitis severity and to compare it with the biomarkers and severity scores currently used for that purpose.

Patients and Methods

Prospective single-center observational study enrolling 268 adult patients with acute pancreatitis. Biomarkers including PSP were measured upon admission to the Emergency Department and severity scores as SOFA, PANC-3, and BISAP were computed. Patients were classified into mild-moderate (non-severe) and severe acute pancreatitis according to the Determinant-Based Classification Criteria. Area under the curve (AUC) and regression analysis were used to analyze the discrimination abilities and the association of biomarkers and scores with severity.

Results

Two hundred and thirty-five patients (87.7%) were classified as non-severe and 33 (12.3%) as severe acute pancreatitis. Median [IQR] PSP was increased in patients with severe acute pancreatitis (890 μg/L [559–1142] vs. 279 μg/L [141–496]; p < 0.001) and it was the best predictor (ROC AUC: 0.827). In multivariate analysis, PSP and urea were the only independent predictors for severe acute pancreatitis and a model combining them both (“biomarker model”) showed an AUC of 0.841 for prediction of severe acute pancreatitis, higher than the other severity scores.

Conclusions

PSP is a promising biomarker for predicting the severity of acute pancreatitis upon admission. A model combining PSP and urea might further constitute a potential tool for early risk stratification of this disease.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Abbreviations

APACHE:

Acute Physiology and Chronic Health Evaluation

AUC:

Area under the curve

BISAP:

Bedside Index for Severity in Acute Pancreatitis

CBC:

Cell blood count

CRP:

C-reactive protein

DBC:

Determinant-Based Classification

ED:

Emergency Department

ICU:

Intensive Care Unit

PSP:

Pancreatic stone protein

ERCP:

Post-endoscopic retrograde cholangiopancreatography pancreatitis

SOFA:

Sequential organ failure assessment

ROC:

Receiver operating characteristic

References

  1. Méndez-Bailón M, De Miguel Yanes JM, Jiménez García R, Hernández-Barrera V, Pérez-Farinós N, Lopez-de-Andrés A. National trends in incidence and outcomes of acute pancreatitis among type 2 diabetics and non-diabetics in Spain (2001–2011). Pancreatology. 2019;15:64–70.

    Article  Google Scholar 

  2. Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet. 2015;386:85–96.

    Article  Google Scholar 

  3. Hines OJ, Pandol SJ. Management of severe acute pancreatitis. BMJ. 2019;367:I6227.

    Article  Google Scholar 

  4. Silva-Caz P, Abrantes AM, Castelo-Branco M, Gouveia A, Botelho MF, Tralhao JG. Multifactorial scores and biomarkers of prognosis of acute pancreatitis: Applications to research and practice. Int J Mol Sci. 2020;21:338.

    Article  Google Scholar 

  5. Leppaniemi A, Tolonen M, Tarasconi A et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019;14:27.

    Article  Google Scholar 

  6. Miko A, Vigh E, Matrai P, Soos A, Garami A, Balasko M. Computed Tomography Severity Index vs. other Indices in the prediction of severity and mortality in acute pancreatitis: A predictive accuracy meta-analysis. Front Physiol. 2019;10:1002.

    Article  Google Scholar 

  7. Forsmark CE, Vege SS, Wilcox CM. Acute pancreatitis. N Engl J Med.. 2017;376:598–599.

    PubMed  Google Scholar 

  8. Valverde-López F, Wilcox CM, Redondo-Cerezo E. Evaluation and management of acute pancreatitis in Spain. Gastroenterol Hepatol. 2018;41:618–628.

    Article  Google Scholar 

  9. Prazak J, Irincheeva I, Llewelyn MJ et al. Accuracy of pancreatic stone protein for the diagnosis of infection in hospitalized adults: a systematic review and individual patient level meta-analysis. Crit Care. 2021;25:182.

    Article  Google Scholar 

  10. de Guadiana Romualdo LG, Albaladejo-Otón MD, Berger M et al. Prognostic performance of pancreatic stone protein in critically ill patients with sepsis. Biomarker Med. 2019;13:1469–1480.

    Article  Google Scholar 

  11. Reding T, Palmiere C, Pazhepurackel C et al. The pancreas responds to remote damage and systemic stress by secretion of the pancreatic secretory proteins PSP/regI and PAP/regIII. Oncotarget. 2017;8:30162–30174.

    Article  Google Scholar 

  12. Nakae Y, Naruse S, Kitagawa M et al. Molecular forms of serum pancreatic stone protein in acute pancreatitis. Int J Pancreatol. 1999;25:17–21.

    CAS  Article  Google Scholar 

  13. Maraví Poma E, Zubia Olascoaga F, Petrov MS et al. Recommendations for intensive care management of acute pancreatitis. Med Intensiva. 2012;2013:163–179.

    Google Scholar 

  14. Bruno MJ, Dellinger EP, Forsmark CE et al. Determinant-based classification of acute pancreatitis severity: An international multidisciplinary consultation. Ann Surg. 2012;256:875–880.

    Article  Google Scholar 

  15. Kolber W, Kuśnierz-Cabala B, Dumnicka P et al. Serum urokinase-type plasminogen activator receptor does not outperform C-reactive protein and procalcitonin as an early marker of severity of acute pancreatitis. J Clin Med. 2018;7:305.

    CAS  Article  Google Scholar 

  16. Gurusamy KS, Debray TPA, Rompianesi G. Prognostic models for predicting the severity and mortality in people with acute pancreatitis. Cochrane Database Syst Rev. 2018;2018:CD013026.

    PubMed Central  Google Scholar 

  17. Valverde-López F, Matas-Cobos AM, Alegría-Motte C, Jiménez-Rosales R, Úbeda-Muñoz M, Redondo-Cerezo E. BISAP, RANSON, lactate and other biomarkers in prediction of severe acute pancreatitis in an European cohort. J Gastroenterol Hepatol. 2017;32:1649–1656.

    Article  Google Scholar 

  18. De-Madaria E, Molero X, Bonjoch L et al. Oleic acid chlorohydrin, a new early biomarker for the prediction of acute pancreatitis severity in humans. Ann Intensive Care. 2018;8:1.

    CAS  Article  Google Scholar 

  19. Sternby H, Bolado F, Canaval-Zuleta HJ et al. Determinants of severity in acute pancreatitis: a nation-wide multicenter prospective cohort study. Ann Surg. 2019;270:348–355.

    Article  Google Scholar 

  20. Staubli SM, Oertli D, Nebiker CA. Laboratory markers predicting severity of acute pancreatitis. Crit Rev Clin Lab Sci. 2015;52:273–283.

    CAS  Article  Google Scholar 

  21. Mayer JM, Raraty M, Slavin J et al. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg. 2002;89:163–171.

    CAS  PubMed  Google Scholar 

  22. Liang Y, Zhao X, Meng F. Procalcitonin, C-reactive protein, and neutrophil ratio contribute to the diagnosis and prognosis of severe acute pancreatitis. Iran J Public Health. 2019;48:2177–2186.

    PubMed  PubMed Central  Google Scholar 

  23. van den Berg FF, de Bruijn AC, van Santvoort HC, Issa Y, Boermeester MA. Early laboratory biomarkers for severity in acute pancreatitis. A systematic review and meta-analysis. Pancreatology. 2020;20:1302–1311.

    Article  Google Scholar 

  24. Siriwardena AK, Jegatheeswaran S, Mason JM et al. PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): Study protocol for a randomised controlled trial. Trials. 2019;20:463.

    Article  Google Scholar 

  25. Hagjer S, Kumar N. Evaluation of the BISAP scoring system in prognostication of acute pancreatitis: A prospective observational study. Int J Surg. 2018;54:76–81.

    Article  Google Scholar 

  26. Zhou H, Mei X, He X, Lan T, Guo S. Severity stratification and prognostic prediction of patients with acute pancreatitis at early phase: A retrospective study. Medicine (Baltimore). 2019;98:e15275.

    Article  Google Scholar 

  27. Choi JH, Kim MH, Cho DH et al. Revised Atlanta classification and determinant-based classification: Which one better at stratifying outcomes of patients with acute pancreatitis? Pancreatology. 2017;17:194–200.

    Article  Google Scholar 

  28. Zhang YP, Liu C, Ye L et al. Early prediction of persistent organ failure by serum angiopoietin-2 in patients with acute pancreatitis. Dig Dis Sci. 2016;61:3584–3591. https://doi.org/10.1007/s10620-016-4323-y.

    CAS  Article  PubMed  Google Scholar 

  29. Shu W, Wan J, Yang X et al. Heparin-binding protein levels at admission and within 24 h are associated with persistent organ failure in acute pancreatitis. Dig Dis Sci. 2020. https://doi.org/10.1007/s10620-020-06660-1.

    Article  PubMed  Google Scholar 

  30. Eggimann P, Que YA, Rebeaud F. Measurement of pancreatic stone protein in the identification and management of sepsis. Biomark Med. 2019;13:135–145.

    CAS  Article  Google Scholar 

Download references

Funding

Abionic SA supported the study by providing reagents and other material for measurement of PSP. Abionic SA participates neither in the study design nor in the analysis or interpretation of the results.

Author information

Author notes

  1. Carlos Rodríguez Rojas and Luis García de Guadiana-Romualdo contributed equally to this manuscript.

Authors and Affiliations

  1. Laboratory Medicine Department, Hospital Universitario Santa Lucía, C/ Mezquita, s/n, Paraje Los Arcos, 30202, Cartagena, Murcia, Spain

    Carlos Rodríguez Rojas, Luis García de Guadiana-Romualdo & María Dolores Albaladejo-Otón

  2. Gastroenterology Department, Hospital Universitario Santa Lucía, C/ Mezquita, s/n, Paraje Los Arcos, 30202, Cartagena, Murcia, Spain

    Senador Morán Sánchez & Virginia Algara Soriano

  3. Department of Intensive Care Medicine, Inselspital; Bern University Hospital, University of Bern, 3010, Bern, Switzerland

    Josef Prazak & Yok-Ai Que

  4. Abionic SA, 1066, Epalinges, Switzerland

    Romy Benninga

Authors
  1. Carlos Rodríguez Rojas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luis García de Guadiana-Romualdo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Senador Morán Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Josef Prazak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Virginia Algara Soriano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yok-Ai Que
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Romy Benninga
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. María Dolores Albaladejo-Otón
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CRR and LGGR designed the study and analyzed the data. LGGR wrote the manuscript. SMS, JP, YAQ, and MDAO critically reviewed the manuscript. CRR and RB measured PSP levels in blood samples. SMS and VAS contributed to the enrollment of patients and clinical data collection. All authors approved the final version of the manuscript and its submission. All authors are responsible for the entire content of the manuscript.

Corresponding author

Correspondence to Luis García de Guadiana-Romualdo.

Ethics declarations

Conflict of interest

The authors have no conflict of interest.

Ethics approval

The study was approved by the Hospital Ethics Committee (E. O. 2018-51) and was carried out by following the Declaration of Helsinki of the World Medical Association.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rodríguez Rojas, C., García de Guadiana-Romualdo, L., Morán Sánchez, S. et al. Role of Pancreatic Stone Protein as an Early Biomarker for Risk Stratification of Acute Pancreatitis. Dig Dis Sci 67, 3275–3283 (2022). https://doi.org/10.1007/s10620-021-07152-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-021-07152-6

Keywords

  • Acute pancreatitis
  • Severity
  • Prognosis
  • Pancreatic stone protein